ニュース
Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to ...
Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...
There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or ...
5 時間on MSN
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that ...
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
5 日
MedPage Today on MSNSemaglutide Gets FDA Greenlight for MASH
The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...
Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.
5 日on MSN
Semaglutide Drugs Like Ozempic Are Tentatively Linked To Sudden Blindness—Doctors Explain ...
GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...
Scientists at Jiangnan University in China recently found that there is a specific gut microbe known as Bacteroides vulgatus, ...
Weight Loss RX Reviews today published their groundbreaking "2025 American Compounded Semaglutide Consumer Insight Report" – ...
In patients with type 2 diabetes (T2D), treatment with oral semaglutide demonstrated a modest but significant reduction in ...
For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.
4 日
Tuko News on MSNPritty Vishy undergoes semaglutide shots amid alert by health ministry, netizens react
Pritty Vishy has been exploring different things with her body, including cosmetic surgery. She shared a video undergoing ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する